MST

MST
Name	Magnetic Seizure Therapy
Specialty	Psychiatry, Neurology

MST is a neurostimulation procedure used principally for treatment-resistant depressive disorders and select neuropsychiatric conditions. It induces therapeutic seizures via focused alternating magnetic fields using specialized coil systems, aiming to retain efficacy of electroconvulsive therapy while reducing cognitive adverse effects. MST is investigated across clinical trials and translational research programs involving multidisciplinary teams from institutions and regulatory agencies.

Introduction

Magnetic seizure induction protocols were developed within contexts including National Institutes of Health, Massachusetts General Hospital, University of Toronto, King's College London, and collaborative centers in United States, Canada, United Kingdom, Germany, and Japan. Early proponents compared MST with modalities such as Electroconvulsive therapy, repetitive Transcranial magnetic stimulation, and convulsive therapies evaluated in trials at Johns Hopkins Hospital, Columbia University, and University of California, Los Angeles. Key frameworks for clinical translation have involved regulatory consultations with bodies like the Food and Drug Administration and standards set by professional organizations including the American Psychiatric Association and the Royal College of Psychiatrists.

History and Development

Development traces to advances in magnetic stimulation and seizure therapy at institutions such as Walter Reed Army Institute of Research and McLean Hospital, drawing on earlier work by researchers affiliated with Harvard Medical School and University College London. Prototype devices were engineered by teams connected to academic spin-offs and manufacturers with experience in devices used for Transcranial magnetic stimulation and convulsive therapy. Clinical pilot studies were reported in journals linked to societies like the American Neuropsychiatric Association and neurostimulation consortia including collaborators from Stanford University and Yale School of Medicine. Funding and oversight involved grants from agencies such as the National Institute of Mental Health and partnerships with technology firms from Germany and Switzerland.

Clinical Applications and Indications

Primary indications explored include treatment-resistant major depressive disorder evaluated in trials at Massachusetts General Hospital, University of Toronto, and veterans' clinics associated with Department of Veterans Affairs. Investigational uses have encompassed bipolar depression assessed in cohorts at Mayo Clinic and catatonia monitored in inpatient services at Mount Sinai Health System. Case series and early-phase trials have examined applications for obsessive-compulsive disorder in settings affiliated with Columbia University and for suicidality management studied at centers such as University of Pennsylvania.

Mechanisms and Techniques

The technique applies high-frequency alternating magnetic fields via focal coil geometries adapted from designs used at Magstim-affiliated laboratories and university engineering departments including Massachusetts Institute of Technology and ETH Zurich. Stimulation targets are localized to cortical regions informed by neuroimaging from Harvard Medical School-affiliated centers and mapping protocols derived from studies at National Institutes of Health. Anesthesia protocols often mirror perioperative standards from American Society of Anesthesiologists guidelines and use agents common in convulsive therapy research at Johns Hopkins Hospital. Electrophysiological monitoring follows methods validated in trials published by investigators at Stanford University and Karolinska Institutet.

Efficacy and Outcomes

Randomized and open-label studies comparing magnetic seizure induction to electroconvulsive approaches have been conducted at Massachusetts General Hospital, University of California, San Diego, and European centers including Charité – Universitätsmedizin Berlin. Outcomes measured include depressive symptom scales validated by organizations like the World Health Organization and remission criteria used in multicenter trials coordinated with agencies such as the European Medicines Agency. Meta-analyses incorporating trials from Canada, Australia, and South Korea report variable response and remission rates, with several studies noting rapid antidepressant effects comparable to outcomes reported in landmark electroconvulsive therapy trials.

Safety, Side Effects, and Contraindications

Safety profiling draws on adverse event reporting frameworks from the Food and Drug Administration and professional standards from the American Psychiatric Association. Cognitive side-effect assessments have employed neuropsychological batteries standardized at centers including Mount Sinai Health System and Yale School of Medicine, often reporting fewer memory deficits than traditional electroconvulsive therapy trials conducted at Columbia University. Contraindications align with device-safety exclusions used in trials managed by National Institutes of Health investigators and include conditions catalogued by regulatory reviews at European Medicines Agency panels.

Research, Controversies, and Future Directions

Ongoing multicenter trials are registered through institutions collaborating with the National Institute of Mental Health and international networks including investigators from King's College London, University of Toronto, and Sunnybrook Health Sciences Centre. Controversies involve comparative effectiveness versus established therapies debated at conferences hosted by the American Psychiatric Association and methodological disputes raised in editorials from journals associated with The Lancet and JAMA Psychiatry. Future directions emphasize device optimization by engineering groups at Massachusetts Institute of Technology and ETH Zurich, biomarker-guided personalization researched at Stanford University and Karolinska Institutet, and potential regulatory pathways discussed with the Food and Drug Administration and European Medicines Agency.

Category:Neurostimulation